Marginal-Zone Lymphomas The third most common lymphoma, MZL is usually indolent and
often a consequence of chronic antigenic stimulation from a pathogen such as Helicobacter …

Marginal zone lymphomas (MZL) are collectively the second most common indolent
lymphoma comprising 7% of all non-Hodgkin lymphomas with 7,460 patients diagnosed in …

Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are indolent mature B-cell
neoplasms with variable clinical presentation and distinct histopathologic features. Recent …

B-cell lymphomas are neoplastic diseases occasionally associated with chronic
inflammation. mRNA vaccines for coronavirus disease 2019 (COVID-19) induce …

Marginal zone lymphoma (MZL) is an indolent B-cell malignancy with heterogeneous
anatomical and clinical presentation. While MZLs are generally associated with long …

Objective To characterize 414 patients with primary SS who developed haematological
malignancies and to analyse how the main SS-and lymphoma-related features can modify …

Disease overview Marginal zone lymphomas (MZL) are collectively the second most
common type of indolent lymphoma. Diagnosis Three subtypes of MZL are recognized …

Simple Summary Mucosa-associated lymphoid tissue (MALT) lymphoma is the most
common subtype of marginal zone lymphomas. These B-cell neoplasms may arise from …

Extranodal marginal zone lymphoma (EMZL) is a heterogeneous non-Hodgkin lymphoma.
No consensus exists regarding the standard-of-care in patients with advanced-stage …

The primary analysis of MAGNOLIA, an open-label, single-arm, multicenter, phase 2 study,
demonstrated that the next-generation Bruton tyrosine kinase (BTK) inhibitor zanubrutinib …